Curis, Inc. to Present at the 11th Annual Biotechnology Industry Organization (BIO) CEO Investor Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the Company will be presenting at the 11th Annual BIO CEO Investor Conference, at 11:00 a.m. EST on February 10, 2009, at the Waldorf Astoria Hotel in New York, New York.

Back to news